Recent trends in targeted delivery of smart nanocarrier-based microbial enzymes for therapeutic applications

Drug Discov Today. 2024 Feb 8:103915. doi: 10.1016/j.drudis.2024.103915. Online ahead of print.ABSTRACTSmart carrier-based immobilization has widened the use of enzymes for the treatment of several disorders. Large surface areas, tunable morphology, and surface modification ability aid the targeted and controlled release of therapeutic enzymes from such formulations. Smart nanocarriers, such as polymeric carriers, liposomes, and silica have also increased the stability, half-life, and permeability of these enzymes. In this review, summarize recent advances in the smart immobilization of microbial enzymes and their development as precision nanomedicine for the treatment of cancer, thrombosis, phenylketonuria (PKU), and wound healing. We also discuss the challenges and measures to be adopted for the successful clinical translation of these formulations.PMID:38340953 | DOI:10.1016/j.drudis.2024.103915
Source: Drug Discovery Today - Category: Drugs & Pharmacology Authors: Source Type: research